Inside the research

Bio-Rad Laboratories, Inc.

BIO Research profile · latest available data

Price overview

$381.00

▼ -6.54 (-1.7%)

52w hi$390.34
52w lo$241.71
Vol253.60K
As of25 Sep 2026

The Verdict

Hold

Our score +0.47

Short+0.53
Medium+0.57
Long+0.12

computed 2026-09-27

Key fundamentals

Bio-Rad Laboratories, Inc.

Healthcare · Medical Devices

Market cap$10.19B
Enterprise value$9.94B
Trailing P/E46.52x
Forward P/E37.69x
EV / EBITDA22.54x
P / S (ttm)3.94x
Profit margin8.6%
Return on equity3.1%
Revenue growth-0.1%
Earnings growth+18.7%
Debt / equity19.10

Layer Breakdown

LayerRawContribution
Fundamental+0.12
Sector+0.08
Technical+0.40
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

United States · www.bio-rad.com

Risk Metrics

Beta vs SPX0.92
Corr SPX0.36
Annual vol40.7%
Annual ret+15.4%
Sharpe0.38
Max DD-42.1%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-04Earnings Release, Restructuring…read
2026-04-30Earnings Release, Reg FD Disclosure…read
2026-04-24Officer / Director Change, Shareholder Vote…read
2026-02-19Reg FD Disclosureread
2026-02-12Earnings Release, Reg FD Disclosure…read
2025-10-29Earnings Release, Reg FD Disclosure…read
2025-09-30Reg FD Disclosure, Exhibitsread
2025-08-26Reg FD Disclosure, Exhibitsread
2025-07-31Earnings Release, Reg FD Disclosure…read
2025-07-28Officer / Director Change, Other Material Event…read
2025-06-30Other Material Eventread
2025-05-01Earnings Release, Exhibitsread

SEC Filings

DateFormDoc
2026-08-048-Kview
2026-08-0410-Qview
2026-07-284view
2026-05-134view
2026-04-3010-Qview
2026-04-308-Kview
2026-04-284view
2026-04-284view
2026-04-248-Kview
2026-04-234view
2026-04-234view
2026-04-234view
2026-04-234view
2026-03-25DEF 14Aview
2026-03-25ARSview

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Revenue$2.58B+2.0%
Gross profit$1.43B+2.7%
Operating income$47.20M-11.3%
Net income-$1.84B+19.5%
Cash from ops$532.20M+7.1%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$384.14$387.00$376.43$381.00253.60K
Sep 24$377.73$389.38$376.18$387.54374.20K
Sep 23$379.27$382.85$374.77$378.88177.20K
Sep 22$377.53$383.25$374.01$379.57374.70K
Sep 21$381.58$381.58$373.47$377.33311.50K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →